Synthesis and biological study of benzothiophene-fused azaenediyne hybrids as potential anticancer agents

Abstract

Enediyne antibiotics are strong cytotoxic DNA damaging agents with a radical mechanism of action. Here, we report on the synthesis of enediyne analogues using click chemistry as a mild and efficient tool for late-stage modification of the enediyne core. Azaenediyne fused to benzothiophene, which is stable at room temperature while being reactive in the Bergman cyclisation at 37 °C, was chosen as the parent enediyne scaffold. Two approaches were developed for the construction of hybrid molecules by click reactions: the conjugation of the key enediyne with a terminal triple bond handle and various azido-ligands by CuAAC, and an “amine-to-isothiocyanate” addition for the NCS enediyne. While CuAAC required a two-step protocol starting from a Co-protected enediyne, the “amine-to-NCS” addition approach was suitable for the unprotected NCS enediyne directly. Both approaches were successfully applied to synthesise a library of enediyne-containing hybrid molecules with triazole or thiourea linkers. Attaching a Hoechst-like MGB ligand was found to be the most promising strategy for achieving a nanomolar level of enediyne hybrid cytotoxicity. The triazole-containing Hoechst hybrid, which has been proven to localise intracellularly in the nucleus and to be selective for the HeLa cancer cell line, is considered the best candidate for further anticancer drug development.

Graphical abstract: Synthesis and biological study of benzothiophene-fused azaenediyne hybrids as potential anticancer agents

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
09 Oct 2025
Accepted
08 Dec 2025
First published
16 Dec 2025

Org. Biomol. Chem., 2026, Advance Article

Synthesis and biological study of benzothiophene-fused azaenediyne hybrids as potential anticancer agents

E. A. Khmelevskaya, N. A. Danilkina, S. A. Silonov, E. V. Tretyakov, A. F. Khlebnikov, V. E. Melnikov, A. V. Nikitina, A. M. Rumyantsev, M. A. Kryukova and I. A. Balova, Org. Biomol. Chem., 2026, Advance Article , DOI: 10.1039/D5OB01600B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements